Differential diagnosis of the functional and organic diseases of intestine in children.

 

IRRITABLE BOWEL SYNDROME IN CHILDREN

 

                                    

 

             Irritable bowel syndrome (IBS) is a digestive disorder that causes abdominal pain, bloating, gas, diarrhoea, and constipation—or some combination of these problems. IBS affects people of all ages, including children.

              IBS is classified as a functional disorder because it is caused by a problem in how the intestines, or bowels, work. People with IBS tend to have overly sensitive intestines that have muscle spasms in response to food, gas, and sometimes stress. These spasms may cause pain, diarrhoea, and constipation.

                                            

                                            

                               Risk Factors for Irritable Bowel Syndrome

 

                   Symptoms of IBS cannot be traced to a single organic cause. Research suggests that people with IBS seem to have a colon that is more sensitive and reactive than usual to a variety of things, including certain foods and stress. Some evidence indicates that the immune system, which fights infection, is also involved. IBS symptoms can result from the following:

·        The normal motility of the colon may not work properly. It can be spasmodic or can even stop temporarily. Spasms are sudden strong muscle contractions that come and go.

·        The lining of the colon (epithelium), which is affected by the immune and nervous systems, regulates the passage of fluids in and out of the colon. In IBS, the epithelium appears to work properly. However, fast movement of the colon's contents can overcome the absorptive capacity of the colon. The result is too much fluid in the stool. In other patients, colonic movement is too slow, too much fluid is absorbed, and constipation develops.

·        The colon responds strongly to stimuli (for example, foods or stress) that would not bother most people.

 

                      Progression of Irritable Bowel Syndrome

 

              The natural history of IBS is unclear, and generally consists of repeated episodes of intestinal symptoms, which makes initiation of treatment plans difficult.

 

                                                  Causes of IBS

                     The cause of IBS is unknown. Research suggests people with IBS are more sensitive to gas or stool in the colon. People with IBS can also have abnormalities in how their intestines contract, called motility, which refers to the rate stool moves through the intestines. Whereas a faster rate of movement may cause diarrhea, a slower rate may result in constipation.

                   Researchers have proposed many explanations for the increased bowel sensitivity and abnormal bowel motility associated with IBS, such as

Ø reactions to certain foods

Ø overgrowth of bacteria in the colon

Ø psychological stress, including anxiety and depression

Ø problems in the way the brain and the gastrointestinal tract communicate with each other, called the brain-gut connection

            IBS may be a cause of recurring abdominal pain in children. The diagnosis of IBS is based on having abdominal pain or discomfort plus any two of the following:

The pain is relieved by having a bowel movement.

         The onset of pain is associated with a change in the frequency of stools.

The onset of pain is associated with a change in stool consistency.

          The symptoms must be present for at least 12 weeks in the preceding 12 months, and there should be no diseases that might cause the symptoms.

 

             In children IBS affects girls and boys equally and may be diarrhoea-predominant, constipation-predominant, or have a variable stool pattern.

            Children with IBS may also have headache, nausea, or mucus in the stool. Weight loss may occur if a child eats less to try to avoid pain. Some children first develop symptoms after a stressful event, such as teething, a bout with the flu, or problems at school or at home. Stress does not cause IBS, but it can trigger symptoms.

                The frequency and severity of IBS symptoms vary widely and may include:

*    abdominal pain or discomfort

*    intestinal bloating

*    irregular bowel habits, including diarrhea, constipation, or both

*    a change in the appearance of stool, including stools that are loose, hard, thin, or pelletlike

*    mucus in the stool

*    the need to strain to have a bowel movement

*    a sense of urgency when having a bowel movement

*    the sensation of not completely emptying the bowels

      

 

                                          

 

                                                 Diagnostics

                  IBS is diagnosed based on symptoms. A diagnostic manual called Rome III guides doctors in diagnosing and treating functional gastrointestinal disorders, including IBS. According to Rome III, for a child to be diagnosed with IBS, abdominal pain or discomfort must be present at least 1 day per week for a period of 2 months or longer. Two or more of the following must also occur at least 25 percent of the time:

Ø The pain or discomfort is relieved by having a bowel movement.

Ø The pain or discomfort is associated with an increase or decrease in the number of bowel movements.

Ø The pain or discomfort is associated with a change in the appearance of stool.

                                             

                   No test can show if a person has IBS; however, a doctor may run tests to rule out diseases with symptoms similar to IBS. Signs and symptoms that suggest a problem other than IBS include:

·        persistent pain in the upper right or lower right area of the abdomen

·        difficulty swallowing

·        persistent vomiting

·        gastrointestinal bleeding

·        waking up during the night with diarrhea or because of abdominal pain

·        a family history of IBD, celiac disease, or peptic ulcer disease

·        arthritis

·        inflamed, pus-filled masses around the rectum, also called perirectal disease

·        involuntary weight loss

·        a sudden stop in height growth

·        delayed puberty

·        unexplained fever

 

                To diagnose IBS, the doctor will ask questions about symptoms and examine the child to rule out more serious problems or diseases. IBS is not a disease—it is a syndrome, or group of symptoms that occur together. It does not damage the intestine, so if the physical exam and other tests show no sign of disease or damage, the doctor may diagnose IBS.

 

                                         Treatment

                   No cure for IBS exists; however, treatment can reduce symptoms. Treatment is guided by the symptoms present, their severity, and the child’s response to treatment. Treatment includes dietary changes, medication, and stress management.

                                            Dietary Changes

                     Being a chronic gastrointestinal disorder, irritable bowel syndrome (IBS) is closely connected with the food we eat, and the way we eat it. This is why diet plays a very important role in alleviating or aggravating IBS. For the gut to properly function in digesting and moving waste material, a diet, modified according to the needs of the sufferer must be followed. Several food categories and methods of eating are more beneficial and are included in any recommended diet for irritable bowel syndrome sufferers.

                        Reducing or eliminating certain foods may improve symptoms. Common trigger foods include fatty foods, dairy products, carbonated beverages, and caffeine. Keeping a diary of symptoms, bowel habits, and diet may help identify foods that trigger IBS symptoms.

                     Eating high-fiber foods, such as fruits, vegetables, and whole grain breads and cereals, may also help. Fiber helps relieve constipation and promotes regular bowel movements.

                         Eating several small meals throughout the day instead of a few large ones may reduce symptoms.

                      Medications to Control Constipation and Diarrhea

               Fiber supplements, such as Metamucil or Citrucil, help control constipation.

Laxatives, such as PEG 3350 (MiraLax, GlycoLax), mineral oil, or bisacodyl (Dulcolax), relieve moderate to severe constipation.

Loperamide (Imodium) and bismuth subsalicylate (Pepto-Bismol) help relieve diarrhea.

                           

                       Restores the physiological balance of bowel movements through:

Þ   lowering the risk of constipation

Þ   improvement of intestinal microflora

Þ   improvement of the condition of intestinal epithelium

Þ   improvement of the intestinal function

               Antispasmodics, such as dycyclomine (Bentyl), relax smooth muscle contractions in the bowel and can, theoretically, lessen pain related to IBS but should be used with caution due to potentially serious side effects.

             Antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), are used to treat IBS, although their effectiveness in children is not well documented.

              Before taking any of these medications, children and their parents should seek the advice of a health care provider to help weigh the potential benefits against the risk of possible side effects.

                                               Stress Management

 

                     Understanding that IBS is not a life-threatening disease can help reduce a child’s anxiety, which may in turn lessen IBS symptoms. Certain types of counseling, including cognitive behavior therapy and hypnotherapy, have been shown to help manage IBS symptoms. Parents can help reduce a child’s stress by discussing potential IBS-related issues with school personnel—for example, the need for ready access to a private restroom.

 

 

                          Functional abdominal pains

                          Chronic functional abdominal pain (CFAP) is the ongoing presence of abdominal pain for which there is no known medical explanation. It is quite similar to, but less common than, irritable bowel syndrome (IBS), and many of the same treatments for IBS can also be of benefit to those with CFAP. The fundamental difference between IBS and CFAP is that in CFAP, unlike in IBS, there is no change in bowel habits such as constipation or diarrhea. Bowel dysfunction is a necessary diagnostic criteria of IBS.

             CFAP is characterized by chronic pain with no physical explanation or findings (no structural, infectious, or mechanical causes can be found). It is theorized that CFAP is a disorder of the nervous system where normal nociceptive nerve impulses are amplified "like a stereo system turned up too loud" resulting in pain. Alternately it is hypothesized that there exists in the intestine a protozoan (namely blastocystis) which is interacting with the sympathetic nervous system and causing the pain. Newer semi-synthetic antibiotics such as rifaximin have been used in treatment. This visceral hypersensitivity may be a stand-alone cause of CFAP, or CFAP may result from the same type of brain-gut nervous system disorder that underlies IBS. As with IBS, low doses of antidepressants have been found useful in controlling the pain of CFAP.

     

 

                                             

 

             Abdominal pain that cannot be explained by any visible or detectable abnormality, after a thorough physical examination and appropriate further testing if needed, is known as functional abdominal pain. Functional abdominal pain can be intermittent (recurrent abdominal pain or RAP) or continuous. Although the exact cause is not known, nerve signals or chemicals secreted by the gut or brain, may cause the gut to be more sensitive to triggers that normally do not cause significant pain (such as stretching or gas bloating). Because of this change in bowel function, this type of abdominal pain is often referred to as “functional abdominal pain.”

 

                     Parents and children need to be reassured that functional abdominal pain is not life threatening. However, functional abdominal pain may have negative effects on the child’s physical and psychological state. The pain may interfere with school attendance, participation in sports and other extra-curricular activities. Infrequently, it may affect appetite and sleep. The changes in the daily routine may affect the child’s mood and emotions, and in turn cause depression and anxiety. In some cases, children previously suffering from anxiety, depression and other psychiatric disorders may show an exaggerated pain response. Sometimes, the parent and the child may not be consciously aware of any stress or emotional disturbances.    

                    

                       Most young children will point to the umbilicus (belly button) when asked to describe the location of abdominal pain. However, pain centered around the belly button could be due to a number of causes that should be considered w hen evaluating a child with chronic abdominal pain. Some of those causes are not very serious while other causes require close and long term care. Possible causes that should be considered based on the history, physical examination and testing, are acid reflux, constipation, lactose intolerance, parasitic infections of the small and large intestines, infections of the stomach with a germ called Helicobacter pylori (that is associated with ulcers in the first portion of the small bowel), inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerous colitis, celiac disease which is a sensitivity to cereal grains, food allergies, inflammation of the liver (hepatitis), gall bladder problems, an inflamed pancreas,  an intestinal obstruction (blockage), appendicitis, and many more rare disorders. It must be emphasized that typically, none of these more severe problems cause abdominal pain in most children with chronic or recurrent bellyaches. Instead, the pain is usually “functional”.

 

                           Diagnosis

 

                      The diagnosis of functional abdominal pain is often based on the report of symptoms and normal physical examination. It is also quite possible that the doctor may obtain some tests. The reason for these tests is to look for signs of any serious disease. These screening tests may initially include blood and stool tests. The results of screening tests often guide the doctor in deciding whether further tests are needed or whether a trial of diet changes, stress management or medication may be started. Testing should be limited if the history is typical for functional abdominal pain and the child’s physical examination is normal.  In that case, many doctors prefer to treat without testing in order to avoid the discomfort of testing or the slight risk associated with testing.  Of course, if the history, the physical examination, or the results of screening tests are abnormal, further testing may be required.  This further testing may include a test to confirm lactose intolerance, ultrasound of the abdomen, a CT of the abdomen, and upper GI series (radiology test), and possibly an endoscopy (scope). The scope allows the doctor to use a special camera on the scope to look at the inner lining of the food pipe, stomach, first and last portion of the small intestine and the large intestine. At the time of the scope, biopsies (small pinches of the lining) are also obtained and examined under the microscope for signs of certain infections and disorders like IBD and celiac disease. Normal test results in a child without alarm signs or red flags strongly suggest RAP or one of the other types of functional abdominal pain, such as irritable bowel syndrome or functional dyspepsia.  

 

 

                                       Treatment

 

                     If a specific cause for abdominal pain is discovered during the evaluation, the physician will discuss specific management of conditions like constipation, lactose intolerance, infections, IBD, celiac disease, and food allergies. If no specific cause is found and functional abdominal pain is suspected, the child needs to be reassured that his or her abdominal pain is accepted as a real disorder and not something that is “just in the head”. The goal of managing functional abdominal pain is to provide a satisfactory quality of life through support, education, medicines and better coping skills.  Reassurance about the good outcome of functional abdominal pain and the positive aspects of the child’s health are crucial. Addressing the parents’ and child’s concerns and fears and identifying emotional or psychological stressors are also important. As noted before, some tests may be needed during the evaluation of functional abdominal pain, but it is also important for parents and children to know that doing too many unnecessary tests may be frustrating to the family and child. If functional abdominal pain is strongly suspected as the likely diagnosis, testing should be limited to the most useful, simple and relatively non-invasive tests. 

                The child may benefit from certain dietary changes depending on his/her history. These are recommended on a case-by-case basis. The physician may advise avoidance of greasy and spicy foods, caffeine, juices, and carbonated drinks. Eliminating lactose (a natural sugar in milk and other dairy products) from the diet may benefit those who suffer from lactose intolerance in addition to functional abdominal pain. Some children with abdominal pain who also experience “gas” may improve by eating food slowly and by avoiding carbonated drinks, and gas forming foods such as cabbage, or beans. In addition, fruit drinks, sugar-free chewing gum, and sugar free candy sweetened with an alcohol called sorbitol should be avoided.  Sorbitol, which tastes sweet, cannot be properly digested, and when taken in large amounts, it can cause cramping, bloating, and even diarrhea.

                Some children may be candidates for medications, if functional abdominal pain is significantly limiting the daily routine. These medications include anti-spasmodic medicines for those with crampy pain in relation to bowel movements, laxatives for those with constipation, and acid-suppressing medicines for those with pain and dyspepsia. If the child does not respond to any of these treatments, he or she may benefit from low doses of medicines called tricyclic antidepressants (used at much higher doses to treat depression). At low doses, these medicines can be excellent pain relievers for some children. A fearful, anxious, or depressed child however should be fully assessed by a psychiatrist or psychologist. Some psychological treatments that help children cope with functional abdominal pain and other stressors , include behavioral therapy, relaxation exercises and hypnosis. It is very important that the physician, parents, and school encourage the child resume a normal routine.  

 

 

                                     Prognosis

 

                       Fortunately, the diagnosis of functional abdominal pain has a good outcome overall, with almost half of these children getting better on their own or with treatment within a few weeks to months. A supportive and understanding environment at home and school is important to keep the child physically and mentally healthy.    

 

 

                                   Functional constipation

 

 

                     Constipation has been defined as “a delay or difficulty in defecation, present for two or more weeks, sufficient to cause significant distress to the patient. This condition is responsible for an estimated 3 to 5 percent of physician visits by children. Constipation often causes more distress to parents and other caregivers than to the affected child. Many caregivers worry that a child’s constipation is the sign of a serious medical problem.

 

                           

 

                Constipation is responsible for up to 5% of pediatric office visits. It is defined as delay or difficulty in the passing of hard, sometimes large stools for ≥ 2 wk.

The frequency of normal bowel movements varies for infants. In the first year, the average number of bowel movements ranges from 2 to 4/day. This number also varies depending on whether infants are breastfed or formula-fed (breastfed infants have more frequent bowel movements). In general, signs of effort (eg, straining) do not signify constipation; infants only gradually develop the muscles to assist a bowel movement. After age 1 yr, children average 1 bowel movement/day.

 

                                          Etiology

 

              Constipation in children is divided into 2 main types:

·        Organic (5%)

·        Functional (95%)

                Organic: Organic causes involve specific structural, neurologic, toxic/metabolic, or intestinal disorders. They are rare but important to recognize.      The most common cause is Hirschsprung's disease.

                     

                  

 

              Other organic causes that may manifest in the neonatal period or later include:

Ø Anorectal malformations

Ø Cystic fibrosis

Ø Metabolic disorders (eg, hypothyroidism, hypercalcemia, hyperkalemia)

Ø Spinal cord abnormalities

 

 

               Functional: Functional constipation is difficulty passing stools for reasons other than organic causes.

 

                       In infants, the use of formula can lead to small, hard stools.

 

 

                           Causes of constipation in babies

 

§  Babies who are bottle fed often suffer from constipation due to lack of water in their diet.

§  Even breastfed babies may suffer from constipation if their mothers follow improper diet.

§  When a baby is introduced to solids, frequent change in their diet may cause constipation.

§  If the baby takes more of fat or protein but less of fiber then they may suffer from constipation.

§  If a child has infant rickets then also he/she may have constipation.

§  If a child suffers from anemia which is induced by iron deficiency then there are chances of constipation.

§  Hypothyroidism causes constipation.

§  Sometimes allergy to certain food like cow’s milk, eggs or fish may cause inflammation which in turn causes constipation.

§  Sometimes toddlers avoid toilet. They may avoid their toilet trips when her environment changes like when she joins preschool or when she is too busy with playing. Often presence of anal fissures may make defecation painful for which she may avoid defecating.

§  Long term use of medicines like antibiotics and anticonvulsants often result in constipation.

 

Baby constipation effects on a baby’s body

Þ   Constipation often makes babies cranky, lethargic and she may lose appetite also.

Þ   Malabsorption of essential vitamins and minerals in the body create imbalance which may finally lead to iron deficiency.

Þ   Constipation in babies may cause inflammation of the intestine which results in abdominal pain.

Þ   Chronic constipation often leads to certain medical complications. Blood circulation in the intestine of the baby may be hampered and inflammation in colon can also occur.

Þ   Cracks may develop in the babies’ rectum due to constipation. Appearance of blood in stool may follow which requires immediate medical attention.

             

 

                      In older children, diets low in fiber and high in dairy lead to hard stools that are uncomfortable to pass and can cause anal fissures. Children sometimes put off having bowel movements because they have discomfort caused by fissures or because they do not want to interrupt play. To avoid having a bowel movement, children may tighten the external sphincter muscles, pushing the stool higher in the rectal vault.

                            

             If this behavior is repeated, the rectum stretches to accommodate the retained stool. The urge to defecate is then decreased, and the stool becomes harder, leading to a vicious circle of painful defecation and worsened constipation. Occasionally, soft stool passes around the impacted stool and leads to stool incontinence.

             Stress, toilet training, desire for control, and sexual abuse are also some of the functional causes of stool retention and subsequent constipation.

 

                                             Evaluation

 

                   Evaluation should focus on differentiating functional constipation from constipation with an organic cause.

                                             History

                     History of present illness in neonates should determine whether meconium has been passed at all and, if so, when. For older infants and children, history should note onset and duration of constipation, frequency and consistency of stools, and timing of symptoms—whether they began after a specific event, such as introduction of certain foods or a stressor that could lead to stool retention (eg, introduction of toilet training). Important associated symptoms include soiling (stool incontinence), discomfort during defecation, and blood on or in the stool. The composition of the diet, especially the amount of fluids and fiber, should be noted.

                                 Symptoms of constipation

·        painful bowel movements

·        stomach pain/abdominal distention

·        rectal bleeding from tears (fissures)

·        poor appetite

·        irritability/crankiness

·        urine problems (recurrent infections, bedwetting).

                       Review of systems should ask about symptoms that suggest an organic cause, including new onset of poor suck, hypotonia, and ingestion of honey before age 12 mo (infantile botulism); cold intolerance, dry skin, fatigue, hypotonia, prolonged neonatal hyperbilirubinemia, urinary frequency, and excessive thirst (endocrinopathies); change in gait, pain or weakness in lower extremities, and urinary incontinence (spinal cord defects); night sweats, fever, and weight loss and vomiting, abdominal pain, poor growth, intermittent diarrhea, and constipation (intestinal disorders).

              Past medical history should ask about known disorders that can cause constipation, including cystic fibrosis and celiac sprue. Exposure to constipating drugs or lead paint dust should be noted. Clinicians should ask about delayed passage of meconium within the first 24 to 48 h of life, as well as previous episodes of constipation and family history of constipation.

 

                                      Physical examination

              The physical examination begins with general assessment of the child's level of comfort or distress and overall appearance (including skin and hair condition). Height and weight should be measured and plotted on growth charts.

            Examination should focus on the abdomen and anus and on the neurologic examination.

            The abdomen is inspected for distention, auscultated for bowel sounds, and palpated for masses and tenderness. The anus is inspected for a fissure (taking care not to spread the buttocks so forcefully as to cause one). A digital rectal examination is done gently to check stool consistency and to obtain a sample for occult blood testing. Rectal examination should note the tightness of the rectal opening and presence or absence of stool in the rectal vault. Examination includes placement of the anus and presence of any hair tuft or pit superior to the sacrum.

                           

                                  Auscultation for bowel sounds

                        In infants, neurologic examination focuses on tone and muscle strength. In older children, the focus is on gait, deep tendon reflexes, and signs of weakness in the lower extremities.

 

                                  Interpretation of findings

                      A primary finding that suggests an organic cause in neonates is constipation from birth; those who have had a normal bowel movement are unlikely to have a significant structural disorder.

                   In older children, clues to an organic cause include constitutional symptoms (particularly weight loss, fever, vomiting), poor growth (decreasing percentile on growth charts), an overall ill appearance, and any focal abnormalities detected during examination. A well-appearing child who has no other complaints besides constipation, who is not on any constipating drugs, and who has a normal examination likely has a functional disorder.

 

                       A distended rectum filled with stool or the presence of an anal fissure is consistent with functional constipation in an otherwise normal child. Constipation that began after starting a constipating drug or that coincides with a dietary change can be attributed to that drug or food. Foods that are known to be constipating include dairy (eg, milk, cheese, yogurt) and starches and processed foods that do not contain fiber. However, if constipation complaints begin after ingestion of wheat, celiac sprue should be considered. History of a new stress (eg, a new sibling) or other potential causes of stool retention behavior, with normal physical findings, support a functional etiology.

                             The following findings are of particular concern:

ü Delayed passage of meconium (> 24 to 48 h after birth)

ü Hypotonia and poor suck (suggesting infant botulism)

ü Abnormal gait and deep tendon reflexes (suggesting spinal cord involvement)

 

                                                    Testing

                      For patients whose histories are consistent with functional constipation, no tests are needed unless there is no response to conventional treatment. An abdominal x-ray should be done if patients have been unresponsive to treatment or an organic cause is suspected. Tests for organic causes should be done based on the history and physical examination.

*    Barium enema, rectal manometry, and biopsy (Hirschsprung's disease)

*    Plain x-rays of lumbosacral spine; MRI considered (tethered spinal cord or tumor)

*    Thyroid-stimulating hormone and thyroxine (hypothyroidism)

*    Blood lead level (lead poisoning)

*    Stool for botulinum toxin (infant botulism)

*    Sweat test and genetic testing (cystic fibrosis)

*    Ca and electrolytes (metabolic derangement)

*    IgA and IgG anti-gliadin antibodies, IgA anti-endomysium antibodies, IgA anti-tissue glutaminase (celiac disease)

 

 

                                            Treatment

 

                      Specific organic causes should be treated. Functional constipation is ideally initially treated with dietary changes and behavior modification.

                    

             Diets high in protein and fiber give the body the essential fuels needed to build muscle, increase energy and exercise to lose fat, rather than muscle. Purify the digestive tract by eating large amounts of roughage like spinach, romaine lettuce, fruit and whole grains and oats. Protein-rich diets help keep everybody full, while fiber-rich.

 

 

                  Dietary changes include adding prune juice to formula for infants, increasing fruits and vegetables for older infants and children, increasing water intake, and decreasing the amount of constipating foods (eg, milk, cheese).

                 Behavior modification for older children involves encouraging regular stool passage after meals if they are toilet trained and providing a reinforcement chart and encouragement to them. For children who are in the process of toilet training, it is sometimes worthwhile to give them a break from training until the constipation concern has passed.

             

                      Unresponsive constipation is treated by disimpacting the bowel and maintaining a regular diet and stool routine. Disimpaction can occur through oral or rectal agents. Oral agents require consumption of large volumes of liquid. Rectal agents can feel invasive and can be difficult to give. Both methods can be done by parents under medical supervision; however, disimpaction sometimes requires hospitalization if outpatient management is unsuccessful. Usually, infants do not require extreme measures, but if intervention is required, a glycerin suppository is typically adequate.                                                     

For maintenance of healthy bowels, some children may require OTC dietary fiber supplements. These supplements require consuming 32 to 64 oz of water/day to be effective.

                       

 

                            Organic bowel disease

                    

The inflammatory bowel disease (IBD) include Crohn's disease and ulcerous colitis.

 

 

            Crohn's disease (also known as granulomatous, and colitis) is an inflammatory disease of the intestines that may affect any part of the gastrointestinal tract from mouth to anus, causing a wide variety of symptoms. It primarily causes abdominal pain, diarrhea (which may be bloody), vomiting, or weight loss, but may also cause complications outside of the gastrointestinal tract such as skin rashes, arthritis, inflammation of the eye, tiredness, and lack of concentration.

           Crohn's disease is thought to be an autoimmune disease, in which the body's immune system attacks the gastrointestinal tract, causing inflammation; it is classified as a type of inflammatory bowel disease. There has been evidence of a genetic link to                                                       Crohn's disease, putting individuals with siblings afflicted with the disease at higher risk. It is understood to have a large environmental component as evidenced by the higher number of cases in western industrialized nations.

          Males and females are equally affected. Smokers are three times more likely to develop Crohn's disease.  Crohn's disease affects between 400,000 and 600,000 people in North America. Prevalence estimates for Northern Europe have ranged from 27–48 per 100,000. Crohn's disease tends to present initially in the teens and twenties, with another peak incidence in the fifties to seventies, although the disease can occur at any age.

            There is no known pharmaceutical or surgical cure for Crohn's disease.Treatment options are restricted to controlling symptoms, maintaining remission and preventing relapse.

 

                    The disease was named for American gastroenterologist Burrill Bernard Crohn, who in 1932, along with two colleagues, described a series of patients with inflammation of the terminal ileum, the area most commonly affected by the illness.

 

                            

 

                                              Classification

 

                           Distribution of gastrointestinal Crohn's disease. Based on data from American Gastroenterological Association.

 

                       Crohn's disease is one type of inflammatory bowel disease (IBD). It affects the gastrointestinal tract and can be categorized by the area of the gastrointestinal tract which it affects. Ileocolic Crohn's disease, which affects both the ileum (the last part of the small intestine that connects to the large intestine) and the large intestine, accounts for fifty percent of cases. Crohn's ileitis, affecting the ileum only, accounts for thirty percent of cases, and Crohn's colitis, affecting the large intestine, accounts for the remaining twenty percent of cases and may be particularly difficult to distinguish from ulcerous colitis. Gastroduodenal Crohn's disease causes inflammation in the stomach and first part of the small intestine, called the duodenum. Jejunoileitis causes spotty patches of inflammation in the top half of the small intestine, called the jejunum. The disease can attack any part of the digestive tract, from mouth to anus. However, individuals affected by the disease fall these three classifications rarely, being affected in other parts of the gastrointestinal tract such as the stomach and esophagus.

 

              Crohn's disease may also be categorized by the behavior of disease as it progresses. This was formalized in the Vienna classification of Crohn's disease.

                There are three categories of disease presentation in Crohn's disease: stricturing, penetrating, and inflammatory. Stricturing disease causes narrowing of the bowel that may lead to bowel obstruction or changes in the caliber of the feces. Penetrating disease creates abnormal passageways (fistulae) between the bowel and other structures such as the skin. Inflammatory disease (or non-stricturing, non-penetrating disease) causes inflammation without causing strictures or fistulae.

 

                     Crohn's Disease - Affected Areas    

                                            

 

                                                          Causes

 

             Although the exact cause of Crohn's disease is still unknown, a combination of environmental factors and genetic predisposition seems to cause the disease. The genetic risk factors have now more or less been comprehensively elucidated, making Crohn's disease the first genetically complex disease of which the genetic background has been resolved. The relative risks of contracting the disease when one has a mutation in one of the risk genes, however, are actually very low (approximately 1:200). Broadly speaking, the genetic data indicate that innate immune systems in patients with Crohn's disease malfunction, and direct assessment of patient immunity confirms this notion. This had led to the notion that Crohn's disease should be viewed as innate immune deficiency, chronic inflammation being caused by adaptive immunity trying to compensate for the reduced function of the innate immune system.

                                                  

                   

 

 

                                               Genetics

 

                  Schematic of NOD2 CARD15 gene, which is associated with certain disease patterns in Crohn's disease.

                  

                   Some research has indicated that Crohn's disease may have a genetic link. The disease runs in families and those with a sibling with the disease are 30 times more likely to develop it than the general population.

                   Mutations in the CARD15 gene (also known as the NOD2 gene) are associated with Crohn's disease and with susceptibility to certain phenotypes of disease location and activity. In earlier studies, only two genes were linked to Crohn's, but scientists now believe there are over thirty genes that show genetics play a role in the disease, either directly through causation or indirectly as with a mediator variable. Anomalies in the XBP1 gene have recently been identified as a factor, pointing towards a role for the unfolded protein response pathway of the endoplasmatic reticulum in inflammatory bowel diseases.

                 

                     

 

 

 

 

                         Environmental factors

 

                           Diet is believed to be linked to its higher prevalence in industrialized parts of the world. A positive correlation has been found between the incidence of the disease and an increased intake of animal protein, milk protein and an increased ratio of n-6 to n-3 polyunsaturated fatty acids. Negative correlation of the disease incidence was found to the increased consumption of vegetable protein, and no correlation to fish protein. Smoking has been shown to increase the risk of the return of active disease, or "flares".

                                                                 

                

                                                      Immune system

 

                        Abnormalities in the immune system have often been invoked as being causes of Crohn's disease. Crohn's disease is thought to be an autoimmune disease, with inflammation stimulated by an over-active Th1 cytokine response. However, more recent evidence has shown that Th17 is of greater importance in the disease.

                         The most recent gene to be implicated in Crohn's disease is ATG16L1, which may induce autophagy and hinder the body's ability to attack invasive bacteria.

                          Contrary to the prevailing view that Crohn's disease is a primary T cell autoimmune disorder, there is an increasing body of evidence in favor of the hypothesis that Crohn's disease results from an impaired innate immunity. The immunodeficiency, which has been shown to be due to (at least in part) impaired cytokine secretion by macrophages, is thought to lead to a sustained microbial-induced inflammatory response, particularly in the colon where the bacterial load is especially high.

         

                                                      

 

            

 

 

 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       


                                                                                     


 

                                                    Microbes

 

               A variety of pathogenic bacteria were initially suspected of being causative agents of Crohn's disease. However, most health care professionals now believe that a variety of microorganisms are taking advantage of their host's weakened mucosal layer and inability to clear bacteria from the intestinal walls, both symptoms of the disease. Some studies have suggested that Mycobacterium avium subspecies paratuberculosis (MAP) plays a role in Crohn's disease, in part because it causes a very similar disease, Johne's disease, in cattle. The mannose bearing antigens (mannins) from yeast may also elicit an antibody response. Other studies have linked specific strains of enteroadherent E. coli to the disease. Still, this relationship between specific types of bacteria and Crohn's disease remains unclear.

 

                  

 

                       

              Some studies have suggested that some symptoms of Crohn's disease, ulcerous colitis and irritable bowel syndrome have the same underlying cause. Biopsy samples taken from the colons of all three patient groups were found to produce elevated levels of a serine protease. Experimental introduction of the serine protease into mice has been found to produce widespread pain associated with irritable bowel syndrome as well as colitis, which is associated with all three diseases.

            

                    

 

                 A study in 2003 put forth the "cold-chain" hypothesis, that psychrotrophic bacteria such as Yersinia spp and Listeria spp contribute to the disease. A statistical correlation was found between the advent of the use of refrigeration in the United States and various parts of Europe and the rise of the disease. Later studies have provided support for this hypothesis.

               Studies done at the University of Liverpool have offered ideas that would explain the apparent connection between Crohn's disease, Mycobacterium, other pathogenic bacteria, and genetic markers. In many individuals genetic factors predispose individuals to Mycobacterium avium subsp. paratuberculosis infection. These bacteria then produce mannins which protect both itself and various bacteria from phagocytosis, which causes a variety of secondary infections. Other mycobacterial diseases, such as leprosy and Tuberculosis could be considered similar in that they have strong genetic components, but are not genetic per se.

                                              Clinics

                 Abdominal pain may be the initial symptom of Crohn's disease. It is often accompanied by diarrhea, especially in those who have had surgery. The diarrhea may or may not be bloody. People who have had surgery or multiple surgeries often end up with short bowel syndrome of the gastrointestinal tract. The nature of the diarrhea in Crohn's disease depends on the part of the small intestine or colon that is involved. Ileitis typically results in large-volume watery feces. Colitis may result in a smaller volume of feces of higher frequency. Fecal consistency may range from solid to watery. In severe cases, an individual may have more than 20 bowel movements per day and may need to awaken at night to defecate. Visible bleeding in the feces is less common in Crohn's disease than in ulcerous colitis, but may be seen in the setting of Crohn's colitis. Bloody bowel movements are typically intermittent, and may be bright or dark red in colour. In the setting of severe Crohn's colitis, bleeding may be copious. Flatulence and bloating may also add to the intestinal discomfort.

              Symptoms caused by intestinal stenosis are also common in Crohn's disease. Abdominal pain is often most severe in areas of the bowel with stenosis. In the setting of severe stenosis, vomiting and nausea may indicate the beginnings of small bowel obstruction. Although the association is greater in the context of ulcerous colitis, Crohn's disease may also be associated with primary sclerosing cholangitis, a type of inflammation of the bile ducts.

               Perianal discomfort may also be prominent in Crohn's disease. Itchiness or pain around the anus may be suggestive of inflammation, fistulization or abscess around the anal area or anal fissure. Perianal skin tags are also common in Crohn's disease. Fecal incontinence may accompany peri-anal Crohn's disease. At the opposite end of the gastrointestinal tract, the mouth may be affected by non-healing sores (aphthous ulcers). Rarely, the esophagus, and stomach may be involved in Crohn's disease. These can cause symptoms including difficulty swallowing (dysphagia), upper abdominal pain, and vomiting.

 

 

                            

Pyoderma gangrenosum on                        Erythema nodosum on the back

a leg of a person with                                      of a person with Crohn's

Crohn's disease.                                                                 disease.      

 

 

                                                      Diagnosis

 

        Endoscopic image of Crohn's colitis showing deep ulceration

       

       CT scan showing Crohn's disease in the fundus of the stomach

 

 

                 

 

 

        

 

          Crohn's disease can mimic ulcerous colitis on endoscopy. This endoscopic image is of Crohn's colitis showing diffuse loss of mucosal architecture, friability of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerous colitis.

                           

           The diagnosis of Crohn's disease can sometimes be challenging, and a number of tests are often required to assist the physician in making the diagnosis. Even with a full battery of tests it may not be possible to diagnose Crohn's with complete certainty; a colonoscopy is approximately 70% effective in diagnosing the disease with further tests being less effective. Disease in the small bowel is particularly difficult to diagnose as a traditional colonoscopy only allows access to the colon and lower portions of the small intestines; introduction of the capsule endoscopy aids in endoscopic diagnosis.

 

                                                 Endoscopy

 

                     A colonoscopy is the best test for making the diagnosis of Crohn's disease as it allows direct visualization of the colon and the terminal ileum, identifying the pattern of disease involvement. Occasionally, the colonoscope can travel past the terminal ileum but it varies from patient to patient. During the procedure, the gastroenterologist can also perform a biopsy, taking small samples of tissue for laboratory analysis which may help confirm a diagnosis. As 30% of Crohn's disease involves only the ileum, cannulation of the terminal ileum is required in making the diagnosis. Finding a patchy distribution of disease, with involvement of the colon or ileum but not the rectum, is suggestive of Crohn's disease, as are other endoscopic stigmata. The utility of capsule endoscopy for this, however, is still uncertain.

                                                                          

 

 

 

                                                      Radiologic tests

 

                      A small bowel follow-through may suggest the diagnosis of Crohn's disease and is useful when the disease involves only the small intestine. Because colonoscopy and gastroscopy allow direct visualization of only the terminal ileum and beginning of the duodenum, they cannot be used to evaluate the remainder of the small intestine. As a result, a barium follow-through x-ray, wherein barium sulfate suspension is ingested and fluoroscopic images of the bowel are taken over time, is useful for looking for inflammation and narrowing of the small bowel. Barium enemas, in which barium is inserted into the rectum and fluoroscopy used to image the bowel, are rarely used in the work-up of Crohn's disease due to the advent of colonoscopy. They remain useful for identifying anatomical abnormalities when strictures of the colon are too small for a colonoscope to pass through, or in the detection of colonic fistulae.

 

CT and MRI scans are useful for evaluating the small bowel with enteroclysis protocols. They are additionally useful for looking for intra-abdominal complications of Crohn's disease such as abscesses, small bowel obstruction, or fistulae. Magnetic resonance imaging (MRI) is another option for imaging the small bowel as well as looking for complications, though it is more expensive and less readily available.

      

                                                       

                                                              Blood tests

 

                              A complete blood count may reveal anemia, which may be caused either by blood loss or vitamin B12 deficiency. The latter may be seen with ileitis because vitamin B12 is absorbed in the ileum. Erythrocyte sedimentation rate, or ESR, and C-reactive protein measurements can also be useful to gauge the degree of inflammation. It is also true in patient with ilectomy done in response to the complication. Another cause of anaemia is anaemia of chronic disease, characterized by its microcytic and hypochromic anaemia. There can be various reasons for anaemia, including medication used in treatment of inflammatory bowel disease like azathioprine which can lead to cytopenia and sulfasalazine which can also result in folate malabsorption, etc. Testing for anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) has been evaluated to identify inflammatory diseases of the intestine and to differentiate Crohn's disease from ulcerous colitis. Furthermore, increasing amounts and levels of serological antibodies such as ASCA, anti-laminaribioside aid in the prognosis of Crohn's disease.

                                     Comparison with ulcerous colitis

 

                             The most common disease that mimics the symptoms of Crohn's disease is ulcerous colitis, as both are inflammatory bowel diseases that can affect the colon with similar symptoms. It is important to differentiate these diseases, since the course of the diseases and treatments may be different. In some cases, however, it may not be possible to tell the difference, in which case the disease is classified as indeterminate colitis.

 

 

 

                                                            Treatment

 

               Currently there is no cure for Crohn's disease and remission may not be possible or prolonged if achieved. In cases where remission is possible, relapse can be prevented and symptoms controlled with medication, lifestyle changes and in some cases, surgery. Adequately controlled, Crohn's disease may not significantly restrict daily living. Treatment for Crohn's disease is only possible when symptoms are active and involve first treating the acute problem, then maintaining remission.

 

                                                          Medication

 

            Acute treatment uses medications to treat any infection (normally antibiotics) and to reduce inflammation (normally aminosalicylate anti-inflammatory drugs and corticosteroids). When symptoms are in remission, treatment enters maintenance with a goal of avoiding the recurrence of symptoms. Prolonged use of corticosteroids has significant side-effects; as a result they are generally not used for long-term treatment. Alternatives include aminosalicylates alone, though only a minority are able to maintain the treatment, and many require immunosuppressive drugs. It has been also suggested that antibiotics change the enteric flora and their continuous use may pose the risk of overgrowth with pathogens such as Clostridium difficile.

                                                      

                     Medications used to treat the symptoms of Crohn's disease include 5-aminosalicylic acid (5-ASA) formulations, prednisone, immunomodulators such as azathioprine, mercaptopurine, methotrexate, infliximab, adalimumab, certolizumab and natalizumab. Hydrocortisone should be used in severe attacks of Crohn's disease.                                        Since late 1990s, biological medications are available.

                                   

                                              Lifestyle changes

 

       Certain lifestyle changes can reduce symptoms, including dietary adjustments, proper hydration and smoking cessation. Smoking may increase Crohn's disease, stopping is recommended. Eating small meals frequently instead of big meals may also help with a low appetite. To manage symptoms have a balanced diet with proper portion control. Fatigue can be helped with regular exercise, a healthy diet, and enough sleep. A food diary may help with identifying foods that trigger symptoms. Some patients should follow a low dietary fiber diet to control symptoms especially if fibrous foods cause symptoms.

                                            Surgery

 

               Crohn's cannot be cured by surgery, though it is used when partial or a full blockage of the intestine occurs. Surgery may also be required for complications such as obstructions, fistulas and/or abscesses, or if the disease does not respond to drugs. After the first surgery, Crohn's usually shows up at the site of the resection though it can appear in other locations. After a resection, scar tissue builds up which can cause strictures. A stricture is when the intestines become too small to allow excrement to pass through easily which can lead to a blockage. After the first resection, another resection may be necessary within five years. For patients with an obstruction due to a stricture, two options for treatment are strictureplasty and resection of that portion of bowel. There is no statistical significance between strictureplasty alone versus strictureplasty and resection in cases of duodenal involvement. In these cases, re-operation rates were 31% and 27%, respectively, indicating that strictureplasty is a safe and effective treatment for selected patients with duodenal involvement.

 

                Short bowel syndrome (SBS, also short gut syndrome or simply short gut) can be caused by the surgical removal of the small intestines. It usually develops if a person has had half or more of their small intestines removed. Diarrhea is the main symptom of short bowel syndrome though other symptoms may include cramping, bloating and heartburn. Short bowel syndrome is treated with changes in diet, intravenous feeding, vitamin and mineral supplements and treatment with medications. Another complication following surgery for Crohn's disease where the terminal ileum has been removed is the development of excessive watery diarrhea. This is due to an inability to reabsorb bile acids after resection of the terminal ileum. 

             In some cases of SBS, intestinal transplant surgery may be considered; though the number of transplant centres offering this procedure is quite small and it comes with a high risk due to the chance of infection and rejection of the transplanted intestine.

 

                                              Prospective treatments

 

               Researchers at University College London have questioned the wisdom of suppressing the immune system in Crohn's, as the problem may be an under-active rather than an over-active immune system: their study found that Crohn's patients showed an abnormally low response to an introduced infection, marked by a poor flow of blood to the wound, and the response improved when the patients were given sildenafil citrate.

 

               Recent studies using helminthic therapy or hookworms to treat Crohn's Disease and other (non-viral) auto-immune diseases seem to yield promising results.

 

                                Complementary and alternative medicine

 

             More than half of Crohn's disease sufferers have tried complementary or alternative therapy. These include diets, probiotics, fish oil and other herbal and nutritional supplements. The benefit of these medications is uncertain.

Acupuncture is used to treat inflammatory bowel disease in China, and is being used more frequently in Western society. However, there is no evidence that acupuncture has benefits beyond the placebo effect. Methotrexate is a folate anti-metabolite drug which is also used for chemotherapy. It is useful in maintenance of remission for those no longer taking corticosteroids.

            Metronidazole and ciprofloxacin are antibiotics which are used to treat Crohn's that have colonic or perianal involvement, although, in the United States, this use has not been approved by the Food and Drug Administration. They are also used for treatment of complications, including abscesses and other infections accompanying Crohn's disease.

  

                                Ulcerous colitis

 

             Ulcerous colitis is the illness called inflammatory bowel disease (IBD). 

 

                     In ulcerous colitis, the inner lining of the large intestine or bowel (colon) and the rectum become inflamed (irritated or raw and swollen). Ulcerous colitis can affect the entire colon, but it is usually in the rectum and the lower part of the colon. Inflammation from ulcerous colitis can make the colon empty often, which causes diarrhea. Ulcers form, causing bleeding.

 

 

      

                                             

 

                                                                   Causes

                      There is no known cause for ulcerous colitis, but there are many theories about its cause. One theory is that the body's immune system (that fights off infection) reacts to a virus or bacteria. This reaction cannot stop and causes chronic (ongoing) inflammation in the intestine.

                 It has been proven that patients with ulcerous colitis have abnormalities (problems) in the immune system. It is not known if these abnormalities are a cause of the disease or a result of the disease. There is little evidence that ulcerous colitis is caused by emotional distress or allergy to certain foods.

 

                     The most common symptoms of ulcerous colitis are stomach pain and bloody diarrhea (loose bowel movements).

                        Other symptoms that can occur include:

Ø Rectal bleeding (blood in bowel movements)

Ø Fatigue (tiredness)

Ø Loss of appetite

Ø Weight loss

Ø Skin problems

Ø Joint pain

Ø Stunted growth

 

                                     Diagnostics

 

                  Ulcerous colitis is diagnosed by a complete medical history and physical examination along with medical tests. The main goal of the tests is to make sure that the disease is ulcerous colitis and not some other kind of disease that causes diarrhea.

 

                              Testing for ulcerous colitis includes the following:

Blood tests check for anemia (low red blood cell count), which can mean bleeding in the colon or rectum. They can also show if there is an increased number of white blood cells, which might mean that there is inflammation somewhere in the body.

 

Stool cultures tell if there is an infection by a parasite, virus or bacteria. Stool can also be tested for occult (hidden) blood that is not seen on the stool.

Sigmoidoscopy is a test using a flexible tube with a light and camera lens at the end (sigmoidoscope) that is put into the rectum and lower colon (sigmoid colon). It lets the doctor see inflammation in the lining of the rectum and lower colon.      

               

 

 

 

                    

 

 

Colonoscopy is a test that uses a long, flexible tube with a light and camera lens at the end (colonoscope). This allows the doctor to examine the lining of the entire colon.

Biopsy is a tissue sample that is taken for examination and testing in a laboratory. In ulcerous colitis, a biopsy (a small piece of tissue from the lining of the large bowel) is usually done during a sigmoidoscopy or colonoscopy.

Barium enema / X-ray is a procedure that examines the large intestine for abnormalities. A chalky fluid called barium is put into the rectum as an enema. The barium coats the inside of the colon so that it will show up on an X-ray film (picture). An X-ray of the colon shows ulcers (sores) and other problems.

 

                     

                            

                                         Treatment

                  Treatment for ulcerous colitis is different from one child to another. What helps one patient may not help another. Treatment for ulcerous colitis depends upon many things:

·        Health of the child

·        How much of the colon is inflamed

·        Ability of the child to take certain medicines or undergo certain procedures

 

                         The goal of treatment is to:

Ø Put the disease into remission (making the disease inactive)

Ø Help keep the disease in remiss

Ø Improve the quality of life

                  Some patients go into remission (the symptoms of ulcerous colitis go away). However, it is not uncommon for the symptoms to come back (a "flare").

 

 

                             Specific Carbohydrate Diet

 

                "If there is no clear history of lactose (milk sugar) intolerance, eliminating dairy products from the diet is seldom suggested," according to the Crohn's and Colitis Foundation of America (CCFA), which fears the move might cause calcium deficiency in kids. However, parents looking for an alternative nutritional therapy can cut out lactose while continuing to feed their children healthy sources of calcium. The Specific Carbohydrate Diet (SCD) was created for people with IBD and is based on the theory that if a food is known to cause digestive issues in some people, then avoiding it will help the digestive system heal; because of that, lactose is eliminated, but yogurt that has been fermented for 24 hours to remove lactose, and aged cheeses that contain very little, are allowed. The SCD, developed by Sidney Haas, MD, and biochemist Elaine Gottschall, MD, also requires that starches, sugars and all other complex carbohydrates (disaccharides and polysaccharides) be avoided. This includes grains, breads, rice, corn, potatoes and pasta. But monosaccharides, like honey, fruit and many vegetables, which have a single-molecule structure and are easily digestedare fine, although it should be noted that babies under 12 months old should not eat honey. Also encouraged on the diet are pure proteins like eggs, nuts, meats that haven't been processed or had fillers added and legumes that have been soaked before cooking.

                                         

                                   

 

                                                                      

                                               Dietary Supplements

 

         Fish oil, rich in omega-3 essential fatty acids, may bring relief to kids with colitis by reducing inflammation, according to the information website ulcerative-colitis.org. The Mayo Clinic agrees that fish oil is an anti-inflammatory, and points out that, while never concretely proven, "one study that included large doses of fish oil 15 or more capsules a day suggested a possible benefit." It also mentions a small trial that showed that taking aloe vera gel daily may help, and acknowledge that probiotics might help combat IBD by adding beneficial bacteria to the gut.

 

 

 

                            

            Guidelines for the managements of ulcerous colitis are diagnosed by clinical evaluation, colonoscopy, barium enema, flexible sigmoidoscopy, laboratory tests and stool studies. Treatment of this illness can require numerous adjustments of therapy, depending on the situation and the individual patient. A close working relationship with a gastroenterologist and/or surgeon is essential.

                                  

                                              Medications

 

                  Three different types of medicines may be used to help control the symptoms of ulcerous colitis. Each helps decrease the inflammation in the lining of the colon.

*    Aminosalicylates (5-ASA drugs) alter the body's ability to create and maintain inflammation. These drugs are used to treat mild cases. They may be taken by mouth or given as an enema or suppository. Examples include Asacol", Pentasa", Colazal", Dipentum" and azulfidine.

*    Corticosteroids (such as prednisone) also affect the body's ability to create and maintain inflammation. These medicines are given by mouth or by vein (intravenous) to quiet down medium to severe disease symptoms, but they are not recommended for long-term use because of their side effects. Steroids may also be given as an enema or suppository for inflammation in the last part of the colon.

*    Immunomodulatory medicines are used in patients when aminosalicylates and cortiosteroids do not work or when patients cannot get off the steroids without their symptoms coming back. These drugs quiet down the immune system but they can take as long as three months to work. Some examples are Imuran (azathioprine) and purinethol (6-MP).

 

                                              Surgery

 

                   Most patients with ulcerous colitis do not need surgery. When medicine does not work, about 20 to 30 percent of patients must have surgery. Ulcerous colitis is cured when the colon is removed.

 

                                      Two types of surgery are common:

ü Ileoanal anastomosis. This operation removes the diseased part of the colon. The outer muscles of the rectum are not removed. The ileum is attached inside the rectum, forming a pouch to hold waste. This allows the patient to pass stool through the anus in a normal manner. Bowel movements may be more frequent and watery than usual.

ü Proctocolectomy. This surgery removes the entire colon and rectum. A small opening is then made in the front of the abdominal wall and the tip of the ileum (end of the lower intestine) is brought to the skin's surface (this procedure is called an ileostomy). The opening of the ileostomy (called a stoma allows drainage of waste into a bag (outside of the body).

   

                                                   The Procedure

Ø The colon and rectum are removed.

Ø The anus and surrounding muscles are left in place.

Ø Part of the small intestine is reshaped to form a pouch within the body. The pouch works like a rectum. It stores waste until a bowel movement occurs.

Ø A temporary ileostomy may be needed as the intestine heals. This is a procedure that lets waste pass into a pouch outside the body.

                      Patients can live normal and active lives after surgery.  

 

                                      Risks and Complications

 

Bowel surgery has certain risks and possible complications. They may include:

 

*    Infection

 

*    Injury to nearby organs

 

*    An anastomosis that leaks

 

*    Blood clots

 

*    Risks related to anesthesia

 

                                       

 

 

        Differential diagnosis of Inflammatory Bowel Disease

 

 

Symptoms

Ulcerous Colitis

Crohn's Disease

Diarrhea    

 

Recurrent diarrhea is very common, but onset may be very gradual and mild or it may not be present. Feces may also contain mucus.

Recurrent diarrhea is fairly common.

Rectal Bleeding

Blood is almost always present in stools. It may be readily visible or visible only using a microscope (called occult blood).

Bleeding not as common as in UC, but can occur.

Constipation

Constipation can be a symptom of UC, but not as common as diarrhea. Can occur during flare-ups. May occur when the inflamed rectum triggers a reflex response in the colon that causes it to retain the stool.

Constipation in Crohn's disease is usually a symptom of obstruction in the small intestine.

Abdominal Symptoms

Pain is not prominent symptom, but can vary. May cause vague discomfort in the lower abdomen, an ache around the top of the hipbone, or cramps in the middle of the abdomen. Severe pain can occur during flare-ups. Vomiting and nausea.

Main symptom is recurrent episodes of pain in the lower right part of the abdomen or above the pubic bone. Often preceded by and relieved by defecation. Bloating, nausea, and vomiting may also occur. Intestinal pain may also be an indication of a serious condition, such as an abscess, or a perforation of the intestinal wall.

Fever

May occur with severe attacks.

Usually low-grade. Spiking fever and chills indicates complications.

Loss of appetite, weight loss, and impaired growth in children

Often not evident in mild or even moderately severe UC. Occasionally impairs growth in children and teenagers.

Common. Typical weight loss is 10 - 20% of normal. Commonly impairs growth in children and teenagers.

Abnormal defecation: Increased frequency, a feeling of incomplete evacuation, and tenesmus (a painful urge for a bowel movement even if the rectum is empty). Fecal incontinence.

Symptoms may be mild or severe.

Can occur in active stages.

Anal ulcers and fistulas: (channels that can burrow between organs, loops of the intestine, or between the intestines and skin).

Almost never a symptom.

Fistulas and ulcers around the anus may be early symptoms.

Neurologic or psychiatric symptoms.

 

No.

May be early signs of Crohn's disease when accompanied by gastrointestinal problems.

Note: A 2001 study reporting that early symptoms (called a prodrome) may appear in Crohn's disease, starting about 7 years before the full-blown symptoms occur. The prodrome symptoms included bloating, diarrhea, stomach pain, fever, weight loss, and fatigue. The prodromal period in ulcerous colitis is much shorter (about a year).

 

 

                               Celiac disease

 

 

           Celiac disease is defined as a genetic disorder associated with malnutrition where a person is unable to digest foods which contain the protein gluten, more specifically things that are made from wheat, rye, barely and oats. Though the research of this disease has only recently become popular, the accepted belief is that it is a purely genetic disease that can be triggered by a number of things. This disease often goes undiagnosed because it is so easily mistaken for various other diseases due to the common symptoms. Almost all of the complications and symptoms that arise from this are due to the body's inability to absorb nutrients. The only treatment for this is a gluten free diet that has been found to be highly effective.

             Celiac disease is a known disease of the small intestine. With celiac disease, the intestine experiences an immunological or allergic reaction. The small intestine does not absorb the nutrients of the food digested. This leads to nutritional, vitamin and mineral deficiencies. Diagnosing celiac disease early is very important to prevent any critical illness.

 

 

                                 Actuality

               Celiac disease is common in European countries, particularly in Ireland, Italy, Sweden and Austria. In Finland, the prevalence may be as high as one in every 100 persons. While in North America, its prevalence is one in every 3000 people. Worldwide, its occurrence would be one in every 250 people.

 

               Celiac disease (or celiac sprue) is an autoimmune disorder with a prevalence of approximately 0.5 to 1 percent in the United States. It is associated with inflammation of the mucosa of the small intestine, which may result in villous atrophy. Celiac disease produces a variety of gastrointestinal symptoms that can begin at almost any age. Treatment consists of removal of gluten proteins from the diet, which improves and often eliminates the small intestine pathology.

 

 

                             Pathophysiology and Epidemiology

 

                   Gluten proteins occur throughout our food supply and are relatively resistant to digestive enzymes. Incomplete digestion in the upper gastrointestinal tract results in peptide derivatives that are highly immunogenic to patients with celiac disease. In affected patients, after absorption in the small intestine these proteins interact with the antigen-presenting cells in the lamina propria causing an inflammatory reaction that targets the mucosa of the small intestine. Rye, wheat, and barley, alone or as ingredients in many processed foods, contain gluten and may elicit this immune response.

 

           Two factors are involved in the development of celiac disease—consumption of gluten proteins and genetic predisposition. It is not completely understood how gluten sensitivity begins or whether early exposure to gluten proteins increases the risk of sensitivity. However, almost all patients with celiac disease express human leukocyte antigen (HLA)-DQ2 or HLA-DQ8, which facilitate the immune response against gluten proteins. Concordance rates of 70 to 75 percent among monozygotic twins and 5 to 22 percent among first-degree relatives have been reported. Patients with type 1 diabetes mellitus, Down syndrome, Turner's syndrome, or an associated autoimmune disorder are at increased risk of celiac disease.

 

                                 

 

 

                            

 

                        

 

 

                            Celiac disease: an autoimmune response

 

 

 

                                         Causes

             Celiac, while genetic, can lie dormant for a long period of time, or possibly not even become active at all. It can be triggered through numerous means such as surgery, pregnancy, childbirth, viral infection, or emotional stress. It does tend to become evident in children fairly early on though which allows for more immediate treatment. It seems to be strongly associated with specific HLA genes that result in an immune reaction causing the body to attack itself (autoimmune). This leads to malabsorption of nutrients due to the inflammation and damage of the villi in the intestine (the organs that are responsible for the absorption of the nutrients which are consumed). This is shown in the image below.

 

 

 

 

                              Risk Factors for Celiac Disease    

Risk factor

                       %

Dermatitis herpetiformis

                      100

First-degree relative with celiac disease

                     5 to 22

Autoimmune thyroid disease

                  1.5 to 14

Down syndrome

                     5 to 12

Turner's syndrome

                     2 to 10

Type 1 diabetes mellitus Children

                     3 to 8

Adults

                     2 to 5

 

     

                                     Clinical Diagnosis

 

                                        Symptoms

 

Digestive symptoms are more common in infants and young children and may include

ü abdominal bloating and pain

ü chronic diarrhea

ü vomiting

ü constipation

ü pale, foul-smelling, or fatty stool

ü weight loss

ü protruding abdomen

 

               Most commonly the symptoms begin in children under the age of one, though like stated before they can appear much later in life due to stressors. Almost every symptom is a result of malabsorption; in fact malabsorption is the only symptom of celiac itself. The classic and most immediately noticeable symptoms of celiac disease are, not surprisingly, gastrointestinal: bloating, flatulence, and diarrhea, with smelly stools. The symptoms which become evident include short stature, anemia, weight loss, vomiting, poor appetite, protruding abdomen, gas, bone pain, behaviour changes, muscle cramps, fatigue, joint pain, seizures, numbness in legs, aphthous ulcers, dermatitis herpertiformis, tooth discoloration, and missed menstrual period.

 

 

               Many patients with celiac disease have diarrhea, borborygmus, abdominal pain, and weight loss. However, the disease can affect several organ systems, including the skin, liver, nervous system, bones, reproductive system, and endocrine system. Dermatitis herpetiformis, a pathognomonic skin eruption, occurs in 10 to 20 percent of patients with celiac disease.

        

                            Signs and Symptoms of Celiac Disease

Sign or symptom

Prevalence in patients with celiac disease (%)

                                                            Common

 

Diarrhea

             45 to 85

Fatigue

             78 to 80

Borborygmus

             35 to 72

Abdominal pain

             34 to 64

Weight loss

                 45

Abdominal distention

                 33

Flatulence  

                 28

                                                  Uncommon or rare

Osteopenia or osteoporosis

              1 to 34

Abnormal liver function

              2 to 19

Vomiting

              5 to 16

Iron-deficiency anemia

            10 to 15

Neurologic dysfunction

              8 to 14

Constipation

              3 to 12

Nausea

                 4

 

        

                     

                                     Dermatitis herpetiformis        

                                 

        


 

 

 

Clinical presentation of celiac disease

Infants and young children present with diarrhea, abdominal distension and failure to thrive. However, vomiting, irritability, anorexia and constipation are also common. Older children often present with extra-intestinal manifestations, such as short stature, neurologic symptoms or anemia.


                 Differential Diagnosis of Celiac Disease

*    Anorexia nervosa

 

*    Autoimmune enteropathy

 

*    Bacterial overgrowth

 

*    Collagenous sprue

 

*    Crohn's disease

 

*    Giardiasis

 

*    Human immunodeficiency virus enteropathy

 

*    Hypogammaglobulinemia

 

*    Infective gastroenteritis

 

*    Intestinal lymphoma

 

*    Irritable bowel syndrome

 

*    Ischemic enteritis

 

*    Lactose intolerance

 

*    Other immunodeficiency states

 

*    Soy protein intolerance

 

*    Tropical sprue

 

*    Tuberculosis

 

*    Whipple's disease

 

*    Zollinger-Ellison syndrome        

 

                                       SEROLOGY

 

                The most common serologic markers used for celiac disease screening are serum immunoglobulin A (IgA) endomysial antibodies and IgA tissue transglutaminase (tTG) antibodies. Testing for gliadin antibodies is no longer recommended because of the low sensitivity and specificity for celiac disease. Most studies have found the sensitivity and specificity of testing for IgA endomysial and tTG antibodies to be greater than 95 percent. However the sensitivity depends on the degree of mucosal involvement. In addition, because tTG is the autoantigen recognized by the endomysial antibody, there is rarely a need to perform both tests.16 The tTG antibody test is less costly because it uses an enzyme-linked immunosorbent assay; it is the recommended single serologic test for celiac disease screening in the primary care setting.

                             American Gastroenterological Association Institute

                                  Recommendations for Celiac Disease Screening

 

Consider testing in symptomatic patients at high risk for celiac disease with any of the following conditions:

 

·        Autoimmune hepatitis

·        Down syndrome

·        Premature onset of osteoporosis

·        Primary biliary cirrhosis

·        Unexplained elevations in liver transaminase levels

·        Unexplained iron deficiency anemia

 

Test selectively as part of the medical evaluation when symptoms could be secondary to celiac disease:

 

·        Autoimmune thyroid disease

·        Cerebellar ataxia

·        First- or second-degree relative with celiac disease

·        Irritable bowel syndrome

·        Peripheral neuropathy

·        Recurrent migraine

·        Selective immunoglobulin A deficiency

·        Short stature (in children)

·        Sjgren's syndrome

·        Turner's syndrome

·        Type 1 diabetes mellitus

·        Unexplained delayed puberty

·        Unexplained recurrent fetal loss     

 

                        SMALL BOWEL BIOPSY

 

                 Despite the advent of clinically accurate serologies, a small bowel biopsy is required to confirm the diagnosis of celiac disease for most patients. Biopsy should also be considered in patients with negative serologic test results who are at high risk or in whom the physician strongly suspects celiac disease.

 

However, the mucosal changes may vary from partial to total villous atrophy, or may be characterized by subtle crypt lengthening or increased epithelial lymphocytes. Furthermore, these changes may be patchy, and mucosal abnormalities on intestinal biopsy may be missed. Variations in the severity of pathologic changes on biopsy may obscure the typical changes found in celiac disease, and patients with latent celiac disease may have normal results on small bowel biopsy. Therefore, to avoid false-negative results on endoscopic biopsy, most authorities recommend obtaining at least four tissue samples, which increases the sensitivity of the test.

 

 

Endoscopic and biopsy findings in patients with and without celiac disease

(A) High-definition endoscopic photo of normal small intestine. The villi are clearly visible with no evidence of atrophy or scalloping of the folds.

(B) Biopsy specimen of normal small intestine (hematoxylineosin; original magnification, x 100).

(C) Pill-Cam image of small intestine in a patient with celiac disease, showing scalloping of the mucosal folds (arrows) characteristic of a malabsorption pattern. There is also evidence of villous atrophy compared with normal.

(D) Biopsy specimen of small intestine in a patient with celiac disease (hematoxylineosin; original magnification, x 100). Note the loss of villous architecture.      

 

                             CAPSULE ENDOSCOPY

 

         The biopsy is neither 100 percent sensitive nor specific for celiac disease; other clinical entities, such as infection (e.g., giardiasis, human immunodeficiency virus infection), enteritis, bacterial overgrowth, autoimmune enteropathy, or lymphoma, may have a similar appearance. Capsule endoscopy in this setting may be helpful to distinguish lesions in the jejunum or ileum beyond the reach of the standard endoscope if the diagnosis is in question.

 

                                   Treatment

 

               Treatment of celiac disease is based on avoidance of food products that contain gluten proteins. It is essential that the diagnosis of celiac disease be confirmed before submitting patients to this therapy. Key elements to successful treatment include the motivation of the patient, the attentiveness of the physician to comorbidities that need to be addressed, and the assistance of a dietitian with expertise in gluten-free diets.

                               

                           THE GLUTEN-FREE DIET

 

         Wheat, rye, and barley are the basic grain elements that must be avoided. The role of oats is controversial. Although they provide an excellent source of nutrients and fiber, most commercial products are contaminated with other grains, and only a purified source can be used. The widespread use of glutens in food processing requires patients to pay close attention to labels. Table 6 lists common foods that contain gluten and those that are gluten free.

 

 

                    Gluten Content of Some Common Foods

Category

Contains gluten

Usually gluten free

Breads, cereals, rice, and pasta

 

Bread or pasta made from barley, bran, gluten flour, graham flour, oat bran,* rye, wheat-based semolina, spelt, wheat, or wheat germ

Cereals made with wheat, rye, barley, or oats, or with malt extract or malt flavorings

Bread, cereals, or pasta made from arrowroot corn, buckwheat, corn, cornmeal, hominy, millet, potato starch, rice, rice bran, sago, soy, or tapioca

Puffed corn

Rice (brown or white); rice noodles

 

Vegetables and beans

Creamed or breaded vegetables; some French fries

Canned baked beans

Plain, fresh, frozen, or canned vegetables

Soybeans

 

Fruits        

 

Some commercial fruit pie fillings and dried fruit  

All fruits

Dairy

Malted milk; some milk drinks and flavored or frozen yogurt

Milk and milk products that do not contain gluten additives

Meat, poultry, fish, shellfish, eggs, and nuts

 

Any prepared with barley, oats, rye, wheat, or gluten stabilizers or fillers, including some cold cuts, frankfurters, sandwich spreads, sausages, and canned meats

Plain meat, poultry, fish, and shellfish

Cold cuts, frankfurters, sandwich spreads, and sausages that do not contain gluten fillers

Eggs; nuts and peanut butter        

Snacks and condiments

Many commercial salad dressings, prepared soups, condiments, and sauces

Butter and margarine

Honey; jam and jelly; molasses; sugar

Coconut; hard candy; marshmallows; meringue; plain chocolate

Beverages  

Flavored instant coffees; herbal teas

Hot cocoa mixes; nondairy cream substitutes

Pure instant or ground coffee; tea

Carbonated drinks; fruit juices

*— Pure oats are usually well tolerated but patients should be cautioned that oat products are frequently contaminated with gluten during processing.

Note: This is not a complete list. Patients should read food labels to confirm that food is gluten free. Patients should also check with their pharmacists because some medications contain gluten.

 

 

                     

 

 

 

 

                                         COMPLICATIONS

 

                 Celiac disease is linked with increased mortality. This is primarily because of the risk of malignancy; in particular, non-Hodgkin's lymphoma, which is three to six times more likely in patients with celiac disease. Patients with celiac disease are also at increased risk of oropharyngeal, esophageal, and small intestinal adenocarcinoma. The specific cause of increased malignancy risk is not known; however, several studies support the role of a gluten-free diet in reducing the risk of cancer.

 

                                                     Follow-up

 

      Long-term follow-up of patients with celiac disease is recommended. Serologic markers may be used to monitor compliance with a gluten-free diet. Antibody levels typically return to normal within three to 12 months of starting a gluten-free diet. Lack of response may suggest continued exposure to dietary gluten, which is often inadvertent, and patients should have further dietary instruction to ensure proper compliance with a gluten-free diet.

 

              Most patients who make appropriate dietary changes will improve. If the patient does not respond as expected despite adherence to a gluten-free diet, the physician should consider diseases that may mimic celiac disease, such as microscopic colitis, pancreatic insufficiency, inflammatory bowel disease, ulcerative jejunoileitis, collagenous sprue, and T-cell lymphoma.

 

        A repeat small bowel biopsy three to four months after initiation of a gluten-free diet is not necessary if the patient responds appropriately to therapy. Gluten rechallenge with subsequent small bowel biopsy is no longer recommended. If the diagnosis remains uncertain, or if the response to therapy is not adequate, further diagnostic testing for other diseases should be performed. The natural history of untreated asymptomatic disease has not been delineated.

Referens:

A - Basic:

1.     Pediatrics. Textbook. / O. V. Tiazhka, T. V. Pochinok, A. N. Antoshkina et al. / edited by O. TiazhkaVinnytsia : Nova Knyha Publishers, 2011 – 584 pp. : il.ISBN 978-966-382-355-3

2.     Nelson Textbook of Pediatrics, 19th Edition Kliegman, Behrman. Published by Jenson & Stanton, 2011, 2608.  ISBN: 978-080-892-420-3.

3.     Illustrated Textbook of Paediatrics, 4th Edition.  Published by  Lissauer & Clayden, 2012, 552 p. ISBN: 978-072-343-566-2.

4.     Denial Bernstein. Pediatrics for medical Students. – Second edition, 2012. – 650 p.